Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II
Clinical trial NCT01335477 · COMPLETED
Trial details
- NCT number
- NCT01335477
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-10-01
- Enrollment
- 551
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.